Sanofi, et al. v. Glenmark Pharmaceuticals Inc., et al.C.A. No. 14-264 - RGA, August 28, 2015.

Andrews, J.  Claim Construction Opinion

The Court construed the following claim terms found in U.S. Patent Nos. 8,318,800; 7,323,493; and 8,410,167:

  1. solid pharmaceutical composition
  2. nonionic hydrophilic surfactant
  3. a method of decreasing a risk of cardiovascular hospitalization in a patent; a method of decreasing a risk of hospitalization for atrial fibrillation in a patient having a history of atrial fibrillation or atrial flutter
  4. effective amount
  5. to a patient in need thereof
  6. prevents